Perspective Therapeutics Files 8-K
Ticker: CATX · Form: 8-K · Filed: Oct 11, 2024 · CIK: 728387
Sentiment: neutral
Topics: filing, corporate-update
TL;DR
Perspective Therapeutics (formerly Isoray) filed an 8-K on Oct 11, 2024. Check it for updates.
AI Summary
Perspective Therapeutics, Inc. filed an 8-K on October 11, 2024, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington.
Why It Matters
This filing provides official updates and financial information for Perspective Therapeutics, Inc., which is important for investors and stakeholders to monitor the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events but doesn't inherently indicate high risk on its own.
Key Players & Entities
- Perspective Therapeutics, Inc. (company) — Registrant
- Isoray, Inc. (company) — Former company name
- IsoRay, Inc. (company) — Former company name
- CENTURY PARK PICTURES CORP (company) — Former company name
- October 11, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Perspective Therapeutics, Inc.?
The filing reports "Other Events" and "Financial Statements and Exhibits" as of October 11, 2024.
What were Perspective Therapeutics, Inc.'s former names?
The company was formerly known as Isoray, Inc., IsoRay, Inc., and CENTURY PARK PICTURES CORP.
In which state is Perspective Therapeutics, Inc. incorporated?
Perspective Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Perspective Therapeutics, Inc.?
The business address is 2401 Elliott Avenue, Suite 320, Seattle, Washington 98121.
What is the SIC code for Perspective Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-10-11 08:31:59
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CATX NYSE American LLC I
Filing Documents
- d871448d8k.htm (8-K) — 24KB
- d871448dex991.htm (EX-99.1) — 29KB
- g871448g1011080927256.jpg (GRAPHIC) — 11KB
- 0001193125-24-236468.txt ( ) — 199KB
- catx-20241011.xsd (EX-101.SCH) — 3KB
- catx-20241011_lab.xml (EX-101.LAB) — 18KB
- catx-20241011_pre.xml (EX-101.PRE) — 11KB
- d871448d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated October 11, 2024. 104 Cover Page Interactive Data file (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: October 11, 2024 By: /s/ Johan (Thijs) Spoor Johan (Thijs) Spoor Chief Executive Officer